Meisoindigo, also known as N-Methylisoindigotin and Dian III, is an apoptosis inducer and potential agent for AML. Meisoindigo has been a routine therapeutic agent in the clinical treatment of chronic myelogenous leukemia (CML) in China since the 1980s. Meisoindigo is a promising agent with in vitro and in vivo activity against human acute myeloid leukemia.
Properties:
Density: 1.381 g/cm3
Melting Point: 236-237ºC
Boiling Point: 482ºC at 760 mmHg
Flash Point: 245.3ºC
Refractive Index: 1.698